Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
about
EMT in Breast Carcinoma-A ReviewNEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTUREWNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transitionIdentification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTThe extracellular matrix: a dynamic niche in cancer progressionLoss of Drosophila pseudouridine synthase triggers apoptosis-induced proliferation and promotes cell-nonautonomous EMT.PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.Significance of talin in cancer progression and metastasis.Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinomaBreast cancer cell invasion mediated by Gα12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2.Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.The emerging role of QSOX1 in cancerTropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.Matrix metalloproteinase 1 and circulating tumor cells in early breast cancerE-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.Got a light? Illuminating lung cancer.Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.Inhibitory effect of Erythronium japonicum on the human breast cancer cell metastasis.Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerBioengineering embryonic stem cell microenvironments for the study of breast cancerThree interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.Targeting type Iγ phosphatidylinositol phosphate kinase inhibits breast cancer metastasisHow can grafted breast cancer models be optimized?Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases.Matrix metalloproteinases as breast cancer drivers and therapeutic targets.Increased Epithelial Expression of CTGF and S100A7 with Elevated Subepithelial Expression of IL-1β in Trachomatous Trichiasis.Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.A Drosophila Model of HPV E6-Induced Malignancy Reveals Essential Roles for Magi and the Insulin Receptor
P2860
Q26739625-57DA4746-BBC9-465C-882B-93CD500543F6Q27310099-BBCB26FB-296D-452F-BC96-B6E823C8D618Q27678085-A0AD855D-1014-4B0A-8572-DCE98587A0BFQ28595799-3837CDC1-EF95-4DBA-ABB2-B51665B7B653Q28744173-BD65A211-4153-4961-8867-7A687CFBC69DQ29617793-5D290E10-D7CB-4F2F-9C63-034F7E94A8B8Q30635913-84F9ECED-E81E-433F-A50A-BB26A07A21BDQ33591558-EABE593B-B802-48F8-8DE8-0421EF72093AQ33717428-9D9BD464-51BB-46CA-8645-13740410747DQ33757096-F89F6D72-BA3B-4E4D-8A57-0C76BA01CEEFQ33757116-2CAC4DDC-8FB8-40F9-BFE7-1048E32B1FA9Q33763551-6D81FEB5-698D-4D1E-B3C6-9E63DBD0F7D8Q33769718-506A75EA-A894-44FE-98C5-B778F50DBA0AQ33818687-8ADCC7FD-15FC-4B4B-BFC1-9DECAEEC75A6Q33828083-AAF69325-F750-4891-B3F4-48F7512ED97AQ33828308-4150C7D2-3D99-4AD4-B3BD-FE93A5AC9A4AQ33829455-E6C6AE5F-1A9E-48F7-B4AB-28885446069DQ33839166-1E88CF5B-5393-4F9F-AD0A-7BB1F0293602Q34037623-9D6E60C3-C67D-4EBD-954E-FE042E29D46DQ34049716-2E83C48A-404E-4510-B403-AD38D43F585FQ34133221-9DEF230D-1AA2-430C-9356-4F993409CE23Q34287518-99614EF6-A3BE-4BB9-A73B-316945EE57DCQ34442318-81002907-F7E4-4BF6-AA55-68857D45E1D2Q34444593-C3F5E47C-4B22-4DFC-AE80-E8F87FE038E3Q34490917-336A5205-18F3-4964-BE46-A5A950394DF3Q34606029-EDCF94DE-614D-474B-AC01-314B27DFF680Q34606919-9DEA5E82-FE68-4278-85FD-96196F650B6AQ35050401-AC62C197-FBC4-474F-9E3F-04F8AE51A4ABQ35073648-825C65CC-76E0-407D-9E92-99BD2B76456AQ35206743-E384B590-633F-4CB5-BBC1-5CDEAAA9FDDFQ35586223-A6DA5769-E6A2-4931-94C5-7587110A100BQ35600151-954F7833-07D4-47ED-A822-166CA4B73454Q35683502-31F1720B-881C-44C6-94CD-46648C206D39Q35696228-E6280ACE-C615-44B9-83A0-0DEA9C2A4C03Q35760911-2E4FC101-04D9-46E7-9F73-570FC1410C26Q35762816-9C77D40A-8AF8-4716-BC41-23782F6FDA82Q35892721-4429C233-419C-42F2-BC32-7874061FE487Q36036306-D88AE51B-D6C5-45CB-98EF-7C915B07CF5CQ36078608-0FEF121F-7691-4A01-8A1E-969D28BE4119Q36106815-576B062C-6819-43F5-9299-198216663BA8
P2860
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@ast
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@en
type
label
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@ast
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@en
prefLabel
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@ast
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@en
P2860
P921
P1476
Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.
@en
P2093
Derek C Radisky
Evette S Radisky
P2860
P2888
P304
P356
10.1007/S10911-010-9177-X
P577
2010-05-05T00:00:00Z
2010-06-01T00:00:00Z